SOADOR
GYRE icon

State of Alaska Department of Revenue’s Gyre Therapeutics GYRE Stock Holding History

State of Alaska Department of Revenue’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34K Hold
5,219
– – ﹤0.01% 1985
2026
Q1 		$36K Hold
5,219
– – ﹤0.01% 1968
2025
Q4 		$36K Hold
5,219
– – ﹤0.01% 1978
2025
Q3 		$38K Buy
+5,219
New +$39.6K ﹤0.01% 1840

Other funds holding GYRE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

State of Alaska Department of Revenue's GYRE Position: Q2 2026 in Review

State of Alaska Department of Revenue held its Gyre Therapeutics (GYRE) position steady in Q2 2026 at 5,219 shares worth $34K. The position accounts for ﹤0.01% of the portfolio, ranked #1985.

State of Alaska Department of Revenue first reported a position in GYRE in Q3 2025 and has held it in 4 quarters since. The position peaked at $38K in Q3 2025. 35 funds tracked by Wall St. Rank hold GYRE as of Q2 2026.

  • State of Alaska Department of Revenue held 5,219 shares of Gyre Therapeutics worth $34K as of Q2 2026.
  • State of Alaska Department of Revenue left its Gyre Therapeutics share count unchanged in Q2 2026.
  • Gyre Therapeutics made up ﹤0.01% of State of Alaska Department of Revenue's portfolio in Q2 2026, its #1985 holding.
  • State of Alaska Department of Revenue first reported a position in Gyre Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • State of Alaska Department of Revenue's Gyre Therapeutics position peaked at $38K in Q3 2025.
  • 35 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q2 2026.

Based on State of Alaska Department of Revenue's 13F filing for Q2 2026, filed 20 Jul 2026.